NDC 61958-0705 – Truvada
Emtricitabine 167 mg/1; Tenofovir Disoproxil Fumarate 250 mg/1 · Tablet, Film Coated · Oral
Product NDC61958-0705
Product details
- Brand name
- Truvada
- Generic name
- Emtricitabine and tenofovir disoproxil fumarate
- Labeler
- Gilead Sciences, Inc
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA021752
- Marketed since
- March 10, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Emtricitabine 167 mg/1
- Tenofovir Disoproxil Fumarate 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-0705-1 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0705-1) | Mar 10, 2016 |
Recalls mentioning this NDC
- D-0013-2015 Oct 15, 2014 · Class III
Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Other Truvada products
- 61958-0701 Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Gilead Sciences, Inc
- 61958-0703 Emtricitabine 100 mg/1; Tenofovir Disoproxil Fumarate 150 mg/1 · Tablet, Film Coated · Gilead Sciences, Inc
- 61958-0704 Emtricitabine 133 mg/1; Tenofovir Disoproxil Fumarate 200 mg/1 · Tablet, Film Coated · Gilead Sciences, Inc
- 68071-2112 Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · NuCare Pharmaceuticals,Inc.